TYLER DE WITT: Open Payments
NPI 1518490606 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 75 payments from 14 companies in 2025. Trend: 2023 $1,180 · 2024 $1,813 · 2025 $1,269
Food & beverage: $1,269
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $271 |
| ABBVIE INC. | 18 | $168 |
| Otsuka America Pharmaceutical, Inc. | 9 | $142 |
| Neurocrine BioSciences, Inc. | 7 | $131 |
| Alkermes, Inc. | 5 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| Corium, LLC | 8 | $101 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $39 |
Products named: FANAPT, VRAYLAR, REXULTI, INGREZZA, LYBALVI, CAPLYTA, Azstarys, Jornay PM.
Industry payments across KY — which companies pay providers there.
